$56 Million Settlement Reached Against Hip Implant Manufacturer Biomet
Law 360 reports that Biomet Inc., the manufacturer of the M2a-38 and M2a-Magnum hip implants, have agreed to a $56 million settlement. This settlement will end the federal lawsuit against the company that was consolidated into a Multidistrict Litigation in 2012. The Multidistrict Litigation is entitled In re: Biomet M2a Magnum Hip Implant Products Liability Litigation (MDL 2391) and is pending before The Honorable Judge Robert L. Miller Jr. in the United States District Court for the Northern District of Indiana.
Hundreds of cases have been filed by plaintiffs alleging injuries after being implanted with Biomet hip devices. According to the most recent report issued by the Judicial Panel on Multidistrict Litigation, there are currently over 950 federal cases on file in the Multidistrict Litigation (MDL 2391).
Plaintiffs “qualified” to participate in the settlement are those who are involved in the MDL, received either a Biomet M2a-38 or M2a-Magnum hip implant, and later was required to have that metal hip implant “revised” during the course of a surgery to remove and/or repair the device. Each qualified plaintiff will receive a base payment of $200,000 – and there are of course variations to this base amount based on a variety of court-approved conditions.
The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.